Home › AEterna Zentaris' (AEZS) Buy Rating Reiterated at Canaccord Genuity
 

Keywords :   


AEterna Zentaris' (AEZS) Buy Rating Reiterated at Canaccord Genuity

2016-04-05 02:28:39| Biotech - Topix.net

's stock had its "buy" rating reissued by analysts at Canaccord Genuity in a research report issued on Monday, MarketBeat.Com reports. They presently have a $9.00 price target on the biopharmaceutical company's stock, down from their prior price target of $13.00.

Tags: buy rating aeterna buy rating

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.06Atlantic Tropical Weather Outlook
15.06Eastern North Pacific Tropical Weather Outlook
14.06Bates learned of knighthood at Post Office Inquiry
14.06Chemours Publishes 2023 Sustainability Report
14.06CalPoly Hosts Polymers & Coatings Summer 2024 Short Course
14.06Washington Corner May-June 2024
14.06Boeing plane investigated after 'Dutch roll'
14.06Atlantic Tropical Weather Outlook
More »